decisionhealth Newsletters, Part B News - 2004 Issue 4 (April)
OPT Coverage Expanded
Subscribe or sign in to view the full article.
Article Overview
This article covers a Medicare coverage change affecting ocular photodynamic therapy for age-related macular degeneration, including the newly covered clinical categories, the effective date, and the related payment context for the procedure and drug. It is relevant to ophthalmology practices, especially retina specialists, and to coders and billing staff who track Medicare local and national coverage updates. The article also places the change in context by noting the prior coverage framework and that some uses remain non-covered under Medicare guidance.
Why This Topic Matters
Coverage policy changes can affect whether services are payable, how providers plan treatment delivery, and how billing staff monitor compliance with Medicare requirements. This update is especially relevant for practices that perform retinal procedures and use verteporfin.
What You Will Learn
- What Medicare coverage changed for ocular photodynamic therapy
- Which broad AMD-related conditions were added to coverage
- How the article frames the timing and payment context of the update
- How the expanded policy relates to prior Medicare coverage limitations
Who Should Read This
- Medical coders
- Billing staff
- Ophthalmology practices
- Retina specialists
- Compliance staff
Codes Discussed
Subscribe or sign in to view the full article.


Quick, Current, Complete - www.findacode.com